Drug establishmentActive, Registered FY2026FDA warning letter on file
GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD
GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD is an FDA-registered drug establishment (FEI 1000589993) located in . The facility is active, registered for FY2026. FDA has issued 1 warning letter(s) to this facility.
FDA warning letter
A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.
Establishment record
Inspection history
FDA publishes only a subset of inspection records and Form 483s, so "None on file" is not a guarantee of a clean inspection history.
Questions
Is GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD registered with the FDA?
Yes. GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD is an FDA-registered drug establishment (FEI 1000589993) in . Its current registration status is Active, Registered FY2026.
Has GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD received an FDA warning letter?
Yes. FDA issued a warning letter to GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD; the most recent is dated Sep 30, 2025 (CGMP/Finished Pharmaceuticals/Adulterated).
What does GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD do?
GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD's FDA-registered operations are: MANUFACTURE.
Related facilities
Source: FDA public data · status as of 2026-06-01